Chemical genetics approach to restoring p27Kip1 reveals novel compounds with antiproliferative activity in prostate cancer cells
2010

New Compounds to Fight Prostate Cancer by Restoring p27Kip1

Sample size: 7368 publication Evidence: moderate

Author Information

Author(s): Elizabeth Rico-Bautista, Chih-Cheng Yang, Lifang Lu, Gregory P Roth, Dieter A Wolf

Primary Institution: Sanford-Burnham Medical Research Institute

Hypothesis

Can small molecules restore p27Kip1 protein expression in prostate cancer cells?

Conclusion

The study identified two small molecules, SMIP001 and SMIP004, that can restore p27 levels and inhibit cancer cell growth.

Supporting Evidence

  • SMIP001 and SMIP004 increased nuclear p27 levels in prostate cancer cells.
  • The compounds inhibited CDK2 activity and induced cell cycle delay.
  • SMIP004 downregulated SKP2, leading to p27 stabilization.

Takeaway

Scientists found two new drugs that help a protein called p27 work better in prostate cancer cells, which can slow down cancer growth.

Methodology

A high throughput screening assay was developed using LNCaP prostate cancer cells to identify compounds that restore p27 levels.

Limitations

The exact molecular targets of the identified compounds remain unknown.

Digital Object Identifier (DOI)

10.1186/1741-7007-8-153

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication